← Back to Search

Y2Prevent Intervention for HIV/AIDS

N/A
Waitlist Available
Led By Michele D Kipke, PhD
Research Sponsored by Children's Hospital Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-24 years old;
identify as a cisgender male;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up urine analysis for recent drug use (up to 1 week) at time of assessment (6 months post intervention)
Awards & highlights

Study Summary

This trial is designed to help African American young men who have sex with men develop a healthy vision for their future by defining short- and long-term goals in areas like education and health, with the goal of reducing HIV/STI risk.

Eligible Conditions
  • HIV/AIDS
  • Substance Use

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~urine analysis for recent drug use (up to 1 week) at time of assessment (6 months post intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and urine analysis for recent drug use (up to 1 week) at time of assessment (6 months post intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol and illincit drug use
Illincit drug use
Sexual risk behaviors
Secondary outcome measures
PrEP Uptake

Trial Design

1Treatment groups
Experimental Treatment
Group I: Y2Prevent InterventionExperimental Treatment1 Intervention
Y2Prevent will include several intervention components (i.e., My Legacy, Sources of Influence, Healthy Relationships, Goal Setting, Health and Self-Efficacy, and Mentorship). These intervention components are intended to assist participants: a) explore future adult identity and envision a positive future, b) develop behavioral skills related to problem-solving and goal-setting, c) develop behavioral skills related to communication, negotiation and conflict resolution with romantic and sexual partners, d) identify ways to safeguard their future by taking responsibility for their health, e) obtain information about HIV transmission and HIV prevention, including HIV testing, treatment as prevention (TaSP) and the availability of PrEP and PEP for prevention, and f) a participant-identified mentor to provide support and encouragement related to behavior change and implementing their future goals and plans.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Y2Prevent
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Children's Hospital Los AngelesLead Sponsor
232 Previous Clinical Trials
5,076,741 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,566 Total Patients Enrolled
Michele D Kipke, PhDPrincipal InvestigatorChildren's Hospital Los Angeles
1 Previous Clinical Trials
150 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings to partake in this research initiative?

"Indeed, records on clinicaltrials.gov show that the study is currently recruiting individuals. This particular investigation was first made available to the public in January 22nd 2020 and has recently been updated for July 21st 2022. The research team requires a total of 30 volunteers from one location."

Answered by AI

What criteria must potential participants fulfill in order to qualify for this clinical experiment?

"This study is enlisting thirty eligible individuals, ranging from 18 to 24 years old and with a history of drug use. In addition, participants must identify as cisgender male; Black/African American; gay, bisexual or some other same-sex identity (and/or report having had sex with a man); HIV negative; not currently enrolled in an HIV prevention study; residing within the Los Angeles metropolitan area; equipped with a device (laptop, tablet or phone) connected to the internet for participating in virtual group sessions and completing online surveys plus receiving payment through Venmo or Cash App services; possess access to a telephone for engaging in and"

Answered by AI

What is the aggregate figure of individuals participating in this clinical exploration?

"Affirmative, according to the info hosted on clinicaltrials.gov this research is actively seeking volunteers. It was first posted on January 22nd 2020, and most recently updated July 21st 2022. The study requires 30 participants from a single trial site."

Answered by AI

Is the age limit for this experiment set at thirty years or greater?

"The age range for potential enrollees in this medical trial is 18-24 years old, as per the eligibility criteria."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Y2Prevent: Preventing Drug Use and HIV Through Empowerment, Social Support and Mentorship (Y2P)
Michele D. Kipke 2020. "Y2Prevent: Preventing Drug Use and HIV Through Empowerment, Social Support and Mentorship (Y2P)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04504981.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top